Status:
RECRUITING
Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels
Lead Sponsor:
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Collaborating Sponsors:
Silvana De Giorgi
Davide Bizzoca
Conditions:
Hypovitaminosis D
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients with hypovitaminosis D are randomized into three arms of treatment: Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day...
Detailed Description
Patients with hypovitaminosis D are randomized into three arms of treatment: Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day...
Eligibility Criteria
Inclusion
- Hypovitaminosis D (\<20ng/mL)
Exclusion
- Osteoporosis (T score \<-2.5SD)
- Renal or hepatic diseases
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06138249
Start Date
July 1 2023
End Date
December 30 2025
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bari
Bari, Italy, 70124